Advertisement
Sputnik V vaccine has been developed by the Gamaleya National Research Center of Epidemiology and Microbiology and Russian Direct Investment Fund (RDIF). As per reports, India has purchased 100 million doses of the candidate from Russia.
“Seventeen healthy volunteers were administered Sputnik V vaccine in the last three days as part of human trials,” Dr S K Raut, Head of Clinical Research Department of Noble Hospital here, said.
The inoculation process began on Thursday, he added.
Related Articles
Advertisement
The selection of the volunteers was done as per the laid-down norms as they need to be healthy, doctors said.